Performance indicators of organized cervical screening in Romagna (Italy)

L. Bucchi, F. Falcini, P. Schincaglia, F. Desiderio, A. Bondi, M. Farneti, D. Casadei Giunchi, M. Serafini, D. Canuti, L. Caprara, F. Sabbadini, F. Monari, P. Sassoli

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The availability of published data from organized cervical screening programmes in southern Europe is scant. In the Italian area of Romagna, a first round of organized screening (based on a 3-yearly Pap smear for women aged 25-64 years) was initiated between December 1995 and January 1997 and was completed in an average of 42 months (range 36-48 months). The target population included 305 478 women. Of these, 253 949 were eligible and received a personal letter of invitation. Age-specific screening performance indicators were calculated according to standard methods. The response rate within 6 months of invitation was 49.1% (n=124 621). The total participation rate including women who presented later was 61.7% (n=156 735). The recall rate was 35.2 per 1000 of participants (n=5514). Positive cytology results were distributed as follows: atypical squamous cells of undetermined significance/atypical glandular cells of undetermined significance (ASCUS/AGUS) 40.1%, low-grade squamous intraepithelial neoplasia (LGSIL) 48.6%, high-grade squamous intraepithelial neoplasia (HGSIL) 10.7% and carcinoma 0.7%0. Compliance to colposcopy follow-up was 93.4% (n=5149). The biopsy rate was 52.4% (n=2696) of patients undergoing colposcopy. The detection rate was 4.5 per 1000 of participants (n=707) for CIN2-3 and 0.5 (n=75) for invasive carcinoma. The proportion of microinvasive carcinomas was 36.0% (n=27). The positive predictive value for CIN2-3/carcinoma was 5.8% for the cytology reports of ASCUS/AGUS, 7.6% for those of LGSIL, 76.5% for those of HGSIL, and 100.0% for those of carcinoma (80.4% for combined HGSIL/carcinoma). The ratio of observed to expected (or prevalent to incident) cases of invasive carcinoma was 2.35 (95% confidence interval (CI) 1.85-2.95). In conclusion, most early results of the programme were compatible with an acceptable performance.

Original languageEnglish
Pages (from-to)223-228
Number of pages6
JournalEuropean Journal of Cancer Prevention
Volume12
Issue number3
DOIs
Publication statusPublished - Jun 2003

Fingerprint

Italy
Carcinoma
Colposcopy
Neoplasms
Cell Biology
Papanicolaou Test
Health Services Needs and Demand
Carcinoma in Situ
Squamous Cell Carcinoma
Confidence Intervals
Biopsy
Atypical Squamous Cells of the Cervix

Keywords

  • Cervical cancer
  • Indicator
  • Mass screening
  • Monitoring
  • Pap smear
  • Performance

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Performance indicators of organized cervical screening in Romagna (Italy). / Bucchi, L.; Falcini, F.; Schincaglia, P.; Desiderio, F.; Bondi, A.; Farneti, M.; Giunchi, D. Casadei; Serafini, M.; Canuti, D.; Caprara, L.; Sabbadini, F.; Monari, F.; Sassoli, P.

In: European Journal of Cancer Prevention, Vol. 12, No. 3, 06.2003, p. 223-228.

Research output: Contribution to journalArticle

Bucchi, L, Falcini, F, Schincaglia, P, Desiderio, F, Bondi, A, Farneti, M, Giunchi, DC, Serafini, M, Canuti, D, Caprara, L, Sabbadini, F, Monari, F & Sassoli, P 2003, 'Performance indicators of organized cervical screening in Romagna (Italy)', European Journal of Cancer Prevention, vol. 12, no. 3, pp. 223-228. https://doi.org/10.1097/00008469-200306000-00009
Bucchi, L. ; Falcini, F. ; Schincaglia, P. ; Desiderio, F. ; Bondi, A. ; Farneti, M. ; Giunchi, D. Casadei ; Serafini, M. ; Canuti, D. ; Caprara, L. ; Sabbadini, F. ; Monari, F. ; Sassoli, P. / Performance indicators of organized cervical screening in Romagna (Italy). In: European Journal of Cancer Prevention. 2003 ; Vol. 12, No. 3. pp. 223-228.
@article{b61fe0c8f3064e98bfb6060850986cf3,
title = "Performance indicators of organized cervical screening in Romagna (Italy)",
abstract = "The availability of published data from organized cervical screening programmes in southern Europe is scant. In the Italian area of Romagna, a first round of organized screening (based on a 3-yearly Pap smear for women aged 25-64 years) was initiated between December 1995 and January 1997 and was completed in an average of 42 months (range 36-48 months). The target population included 305 478 women. Of these, 253 949 were eligible and received a personal letter of invitation. Age-specific screening performance indicators were calculated according to standard methods. The response rate within 6 months of invitation was 49.1{\%} (n=124 621). The total participation rate including women who presented later was 61.7{\%} (n=156 735). The recall rate was 35.2 per 1000 of participants (n=5514). Positive cytology results were distributed as follows: atypical squamous cells of undetermined significance/atypical glandular cells of undetermined significance (ASCUS/AGUS) 40.1{\%}, low-grade squamous intraepithelial neoplasia (LGSIL) 48.6{\%}, high-grade squamous intraepithelial neoplasia (HGSIL) 10.7{\%} and carcinoma 0.7{\%}0. Compliance to colposcopy follow-up was 93.4{\%} (n=5149). The biopsy rate was 52.4{\%} (n=2696) of patients undergoing colposcopy. The detection rate was 4.5 per 1000 of participants (n=707) for CIN2-3 and 0.5 (n=75) for invasive carcinoma. The proportion of microinvasive carcinomas was 36.0{\%} (n=27). The positive predictive value for CIN2-3/carcinoma was 5.8{\%} for the cytology reports of ASCUS/AGUS, 7.6{\%} for those of LGSIL, 76.5{\%} for those of HGSIL, and 100.0{\%} for those of carcinoma (80.4{\%} for combined HGSIL/carcinoma). The ratio of observed to expected (or prevalent to incident) cases of invasive carcinoma was 2.35 (95{\%} confidence interval (CI) 1.85-2.95). In conclusion, most early results of the programme were compatible with an acceptable performance.",
keywords = "Cervical cancer, Indicator, Mass screening, Monitoring, Pap smear, Performance",
author = "L. Bucchi and F. Falcini and P. Schincaglia and F. Desiderio and A. Bondi and M. Farneti and Giunchi, {D. Casadei} and M. Serafini and D. Canuti and L. Caprara and F. Sabbadini and F. Monari and P. Sassoli",
year = "2003",
month = "6",
doi = "10.1097/00008469-200306000-00009",
language = "English",
volume = "12",
pages = "223--228",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Performance indicators of organized cervical screening in Romagna (Italy)

AU - Bucchi, L.

AU - Falcini, F.

AU - Schincaglia, P.

AU - Desiderio, F.

AU - Bondi, A.

AU - Farneti, M.

AU - Giunchi, D. Casadei

AU - Serafini, M.

AU - Canuti, D.

AU - Caprara, L.

AU - Sabbadini, F.

AU - Monari, F.

AU - Sassoli, P.

PY - 2003/6

Y1 - 2003/6

N2 - The availability of published data from organized cervical screening programmes in southern Europe is scant. In the Italian area of Romagna, a first round of organized screening (based on a 3-yearly Pap smear for women aged 25-64 years) was initiated between December 1995 and January 1997 and was completed in an average of 42 months (range 36-48 months). The target population included 305 478 women. Of these, 253 949 were eligible and received a personal letter of invitation. Age-specific screening performance indicators were calculated according to standard methods. The response rate within 6 months of invitation was 49.1% (n=124 621). The total participation rate including women who presented later was 61.7% (n=156 735). The recall rate was 35.2 per 1000 of participants (n=5514). Positive cytology results were distributed as follows: atypical squamous cells of undetermined significance/atypical glandular cells of undetermined significance (ASCUS/AGUS) 40.1%, low-grade squamous intraepithelial neoplasia (LGSIL) 48.6%, high-grade squamous intraepithelial neoplasia (HGSIL) 10.7% and carcinoma 0.7%0. Compliance to colposcopy follow-up was 93.4% (n=5149). The biopsy rate was 52.4% (n=2696) of patients undergoing colposcopy. The detection rate was 4.5 per 1000 of participants (n=707) for CIN2-3 and 0.5 (n=75) for invasive carcinoma. The proportion of microinvasive carcinomas was 36.0% (n=27). The positive predictive value for CIN2-3/carcinoma was 5.8% for the cytology reports of ASCUS/AGUS, 7.6% for those of LGSIL, 76.5% for those of HGSIL, and 100.0% for those of carcinoma (80.4% for combined HGSIL/carcinoma). The ratio of observed to expected (or prevalent to incident) cases of invasive carcinoma was 2.35 (95% confidence interval (CI) 1.85-2.95). In conclusion, most early results of the programme were compatible with an acceptable performance.

AB - The availability of published data from organized cervical screening programmes in southern Europe is scant. In the Italian area of Romagna, a first round of organized screening (based on a 3-yearly Pap smear for women aged 25-64 years) was initiated between December 1995 and January 1997 and was completed in an average of 42 months (range 36-48 months). The target population included 305 478 women. Of these, 253 949 were eligible and received a personal letter of invitation. Age-specific screening performance indicators were calculated according to standard methods. The response rate within 6 months of invitation was 49.1% (n=124 621). The total participation rate including women who presented later was 61.7% (n=156 735). The recall rate was 35.2 per 1000 of participants (n=5514). Positive cytology results were distributed as follows: atypical squamous cells of undetermined significance/atypical glandular cells of undetermined significance (ASCUS/AGUS) 40.1%, low-grade squamous intraepithelial neoplasia (LGSIL) 48.6%, high-grade squamous intraepithelial neoplasia (HGSIL) 10.7% and carcinoma 0.7%0. Compliance to colposcopy follow-up was 93.4% (n=5149). The biopsy rate was 52.4% (n=2696) of patients undergoing colposcopy. The detection rate was 4.5 per 1000 of participants (n=707) for CIN2-3 and 0.5 (n=75) for invasive carcinoma. The proportion of microinvasive carcinomas was 36.0% (n=27). The positive predictive value for CIN2-3/carcinoma was 5.8% for the cytology reports of ASCUS/AGUS, 7.6% for those of LGSIL, 76.5% for those of HGSIL, and 100.0% for those of carcinoma (80.4% for combined HGSIL/carcinoma). The ratio of observed to expected (or prevalent to incident) cases of invasive carcinoma was 2.35 (95% confidence interval (CI) 1.85-2.95). In conclusion, most early results of the programme were compatible with an acceptable performance.

KW - Cervical cancer

KW - Indicator

KW - Mass screening

KW - Monitoring

KW - Pap smear

KW - Performance

UR - http://www.scopus.com/inward/record.url?scp=12444275236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12444275236&partnerID=8YFLogxK

U2 - 10.1097/00008469-200306000-00009

DO - 10.1097/00008469-200306000-00009

M3 - Article

VL - 12

SP - 223

EP - 228

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - 3

ER -